Ambev S.A. (ABEV) Tops Q2 EPS by 12c

Ambev S.A. (NYSE: ABEV) reported Q2 EPS of R$0.15, R$0.12 better than the analyst estimate of R$0.03. Revenue for the quarter came in at R$20.04 billion versus the consensus estimate of R$3.56 billion.

For earnings history and earnings-related data on Ambev S.A. (ABEV) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Hertz completes $350 million senior secured notes offering
• FDA selects seven participants for precheck pilot program to advance U.S. drug manufacturing